← SynDRA
MK-886
SynDRA canonical compound SYN1962023 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ALOX5AP |
|---|
| Mechanism of action | lipoxygenase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- MK 886
- MK886
- 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-isopropyl-1H-indol-2-yl)-2,2-dimethylpropanoic acid
- UNII-080626SQ8C
- QAOAOVKBIIKRNL-UHFFFAOYSA-N
- L-663,536
- CHEMBL29097
- CHEBI:75390
- L-663536
- MK-886 (L-663,536)
- 080626SQ8C
- 3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-propan-2-ylindol-2-yl]-2,2-dimethylpropanoic acid
- 1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-Alpha,Alpha-dimethyl-5-(1-methylethyl)- [CAS]
- SMR000466278
Look up MK-886 in the interactive SynDRA portal →